Tuesday, September 18, 2012

vasopharm's Traumatic Brain Injury Drug Exceeds Expectations in Phase IIa Exploratory Clinical Trial

vasopharm's Traumatic Brain Injury Drug Exceeds Expectations in Phase IIa Exploratory Clinical Trial

No comments:

Post a Comment